Sinopharm Group Ownership
| SHTDF Stock | USD 2.40 0.29 13.74% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Sinopharm |
Sinopharm Pink Sheet Ownership Analysis
About 51.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.88. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sinopharm Group last dividend was issued on the 27th of June 2022. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd. Sinopharm Group is traded on OTC Exchange in the United States.The quote for Sinopharm Group Co is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sinopharm Group Co contact the company at 86 21 2305 2666 or learn more at https://www.sinopharmgroup.com.cn.Currently Active Assets on Macroaxis
| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp | |
| BTE | Baytex Energy Corp | |
| SOXS | Direxion Daily Semiconductor |
Other Information on Investing in Sinopharm Pink Sheet
Sinopharm Group financial ratios help investors to determine whether Sinopharm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinopharm with respect to the benefits of owning Sinopharm Group security.